Tag: antibodies

Inflammation becomes a problem when our immune system stays on guard unnecessarily, and worst is when it is not just patrolling, but starts firing too, writes Dr Anju Dave Vaish.........................

Covid-19 Neutralizing Antibody Microlisa Elisa Test is the first commercial laboratory test to detect neutralizing antibodies against SARS-CoV-2, the virus that causes Covid-19......................

Padma Shree Presidential Awardee and Dr B. C. Roy Presidential Awardee, Doctor Sanjeev Bagai addresses some of the lingering questions around Covid-19 vaccination.......................

In a new study, researchers report that antibody levels in the blood of COVID-19 patients drop rapidly during the weeks after their bodies have cleared the virus and symptoms have subsided............................

CSIR-CDRI is carrying out a research study that involves testing of people for antibodies against SARS-CoV-2. The serological testing was conducted from 9th-11th September.........................

CSIR through its NMITLI program approves a multi institutional project to develop human monoclonal antibodies (hmAbs) that can neutralize SARS-CoV-2 in patients. The project will be implemented by National Centre for Cell Science (NCCS), IIT-Indore and PredOmix Technologies with Bharat Biotech International, as the commercialization partner...........................

A kit under development by the researchers at Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram promises to help detect SARS CoVID-19 infection as early as four days post-infection of the virus...................

Anti-COVID Consortium backed by the Department of Biotechnology involving the public-private partnership is working to produce therapeutic antibodies against SARS-CoV-2......................

The benchtop instrument performs a fully automated iterative fluorescent staining, imaging, and signal erasing process, using multiple fluorochrome-conjugated antibodies per cycle.............

US based Inovio Pharmaceuticals' DNA-encoded monoclonal antibody (dMAb™) platform has made a leap forward with first-in-human trial that will target Zika infection...............